Literature DB >> 18382226

White matter hyperintensities in mid-adult life.

Perminder Sachdev1, Xiaohua Chen, Wei Wen.   

Abstract

PURPOSE OF REVIEW: White matter hyperintensities on T2-weighted magnetic resonance imaging are frequent incidental findings in the brains of elderly individuals. Recent studies have reported that they may also be common in middle-aged individuals, and their systematic evaluation in younger populations is necessary. RECENT
FINDINGS: Incidental white matter hyperintensities are common in brains of healthy individuals in their 60s and may be seen as early as the 30s and 40s. They are associated with subtle functional impairment and higher prevalence of neuropsychiatric disorders. While cerebrovascular risk factors such as hypertension, diabetes, high homocysteine, and so forth, are known risk factors for white matter hyperintensities, a significant proportion of the variance is unexplained. Genetic factors, alone or in interaction with environmental factors, appear to be important. There is a slight excess of white matter hyperintensities in women, the basis for which is not understood. Longitudinal studies show that those with baseline lesions have a greater progression over time.
SUMMARY: New imaging techniques present an opportunity to examine white matter pathology in great detail in younger populations. Standardized methods to examine such pathology and its determinants will help inform strategies for their prevention, which is an important component of a healthy ageing agenda.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382226     DOI: 10.1097/YCO.0b013e3282f945d5

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  15 in total

1.  Functional MR imaging evidence of altered functional activation in metabolic syndrome.

Authors:  K F Hoth; M M Gonzales; T Tarumi; S C Miles; H Tanaka; A P Haley
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

2.  Hypertension is associated with cognitive decline in elderly people at high risk for dementia.

Authors:  Michael Wysocki; Xiaodong Luo; James Schmeidler; Karen Dahlman; Gerson T Lesser; Hillel Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

3.  Reduced retention of Pittsburgh compound B in white matter lesions.

Authors:  Lidia Glodzik; Henry Rusinek; Jinyu Li; Cyrus Zhou; Wai Tsui; Lisa Mosconi; Yi Li; Ricardo Osorio; Schantel Williams; Catherine Randall; Nicole Spector; Pauline McHugh; John Murray; Elizabeth Pirraglia; Shankar Vallabhajolusa; Mony de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-21       Impact factor: 9.236

4.  Qualitative neuropsychological measures: normative data on executive functioning tests from the Framingham offspring study.

Authors:  Lisa D Hankee; Sarah R Preis; Alexa S Beiser; Sherral A Devine; Yulin Liu; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Exp Aging Res       Date:  2013       Impact factor: 1.645

5.  Subclinical atherosclerosis is related to lower neuronal viability in middle-aged adults: a 1H MRS study.

Authors:  Andreana P Haley; Takashi Tarumi; Mitzi M Gonzales; Jun Sugawara; Hirofumi Tanaka
Journal:  Brain Res       Date:  2010-05-10       Impact factor: 3.252

6.  Improving acute stroke management with computed tomography perfusion: a review of imaging basics and applications.

Authors:  C D d'Esterre; Enrico Fainardi; R I Aviv; T Y Lee
Journal:  Transl Stroke Res       Date:  2012-05-24       Impact factor: 6.829

Review 7.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

8.  Morphologic, distributional, volumetric, and intensity characterization of periventricular hyperintensities.

Authors:  M C Valdés Hernández; R J Piper; M E Bastin; N A Royle; S Muñoz Maniega; B S Aribisala; C Murray; I J Deary; J M Wardlaw
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

9.  Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.

Authors:  Malte Lenders; Thomas Duning; Michael Schelleckes; Boris Schmitz; Sonja Stander; Arndt Rolfs; Stefan-Martin Brand; Eva Brand
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

10.  Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.

Authors:  Nicola J Armstrong; Karen A Mather; Muralidharan Sargurupremraj; Maria J Knol; Rainer Malik; Claudia L Satizabal; Lisa R Yanek; Wei Wen; Vilmundur G Gudnason; Nicole D Dueker; Lloyd T Elliott; Edith Hofer; Joshua Bis; Neda Jahanshad; Shuo Li; Mark A Logue; Michelle Luciano; Markus Scholz; Albert V Smith; Stella Trompet; Dina Vojinovic; Rui Xia; Fidel Alfaro-Almagro; David Ames; Najaf Amin; Philippe Amouyel; Alexa S Beiser; Henry Brodaty; Ian J Deary; Christine Fennema-Notestine; Piyush G Gampawar; Rebecca Gottesman; Ludovica Griffanti; Clifford R Jack; Mark Jenkinson; Jiyang Jiang; Brian G Kral; John B Kwok; Leonie Lampe; David C M Liewald; Pauline Maillard; Jonathan Marchini; Mark E Bastin; Bernard Mazoyer; Lukas Pirpamer; José Rafael Romero; Gennady V Roshchupkin; Peter R Schofield; Matthias L Schroeter; David J Stott; Anbupalam Thalamuthu; Julian Trollor; Christophe Tzourio; Jeroen van der Grond; Meike W Vernooij; Veronica A Witte; Margaret J Wright; Qiong Yang; Zoe Morris; Siggi Siggurdsson; Bruce Psaty; Arno Villringer; Helena Schmidt; Asta K Haberg; Cornelia M van Duijn; J Wouter Jukema; Martin Dichgans; Ralph L Sacco; Clinton B Wright; William S Kremen; Lewis C Becker; Paul M Thompson; Thomas H Mosley; Joanna M Wardlaw; M Arfan Ikram; Hieab H H Adams; Sudha Seshadri; Perminder S Sachdev; Stephen M Smith; Lenore Launer; William Longstreth; Charles DeCarli; Reinhold Schmidt; Myriam Fornage; Stephanie Debette; Paul A Nyquist
Journal:  Stroke       Date:  2020-06-10       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.